Wynn RF et al. |
Azithromycin for cerebral toxoplasmosis in AIDS. |
1993 |
Lancet |
pmid:8093526
|
Fortner JH et al. |
Tapetal effect of an azalide antibiotic following oral administration in beagle dogs. |
1993 |
Fundam Appl Toxicol |
pmid:8405779
|
Bailey RL et al. |
Randomised controlled trial of single-dose azithromycin in treatment of trachoma. |
1993 |
Lancet |
pmid:8102427
|
Narcio Reyes LE et al. |
[Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections]. |
1993 |
Ginecol Obstet Mex |
pmid:8406112
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383944
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Cameron DJ |
Effectiveness of early Lyme disease treatment. |
1993 |
Am. J. Med. |
pmid:8388627
|
Melski JW et al. |
Primary and secondary erythema migrans in central Wisconsin. |
1993 |
Arch Dermatol |
pmid:8389536
|
Amacher DE et al. |
Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. |
1993 |
Mutat. Res. |
pmid:7685497
|
Lopatkin NA et al. |
[Use of azithromycin ("Sumamded") in the treatment of infectious-inflammatory diseases of the lower urinary tract and male genitalia]. |
1993 |
Antibiot. Khimioter. |
pmid:8060189
|
Saba J et al. |
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8112357
|
Lefèvre JC et al. |
In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. |
1993 |
Pathol. Biol. |
pmid:8233628
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Meyer AP et al. |
Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285612
|
Lalak NJ and Morris DL |
Azithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8287632
|
Saverino D et al. |
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. |
1993 |
New Microbiol. |
pmid:8264424
|
Pajukanta R |
In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide. |
1993 |
Oral Microbiol. Immunol. |
pmid:8265209
|
Holdcroft C |
Two new macrolide antibiotics: clarithromycin and azithromycin. |
1993 |
Nurse Pract |
pmid:8380492
|
Spangler SK and Appelbaum PC |
Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2. |
1993 |
J. Clin. Microbiol. |
pmid:8381817
|
Gingras BA and Jensen JB |
Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. |
1993 |
Am. J. Trop. Med. Hyg. |
pmid:8394660
|